Juan Carlos Tinoco

2.5k total citations
17 papers, 292 citations indexed

About

Juan Carlos Tinoco is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Medicine. According to data from OpenAlex, Juan Carlos Tinoco has authored 17 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Medicine. Recurrent topics in Juan Carlos Tinoco's work include Antibiotic Resistance in Bacteria (5 papers), Herpesvirus Infections and Treatments (3 papers) and Streptococcal Infections and Treatments (3 papers). Juan Carlos Tinoco is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Herpesvirus Infections and Treatments (3 papers) and Streptococcal Infections and Treatments (3 papers). Juan Carlos Tinoco collaborates with scholars based in Mexico, United States and Belgium. Juan Carlos Tinoco's co-authors include Celia Alpuche‐Aranda, Marı́a Dolores Alcántar-Curiel, Rayo Morfín‐Otero, Bruce L. Innis, Varsha Jain, Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Noris Pavía-Ruz and Aurelio Cruz-Valdéz and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Vaccine.

In The Last Decade

Juan Carlos Tinoco

16 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Carlos Tinoco Mexico 10 137 111 69 56 49 17 292
Naser Eldin Bilal Sudan 12 91 0.7× 156 1.4× 56 0.8× 34 0.6× 58 1.2× 20 324
Jolanta Miciulevičienė Lithuania 10 137 1.0× 81 0.7× 101 1.5× 59 1.1× 39 0.8× 16 327
Dilek Arman Türkiye 12 182 1.3× 181 1.6× 113 1.6× 43 0.8× 63 1.3× 31 468
Jun-Hee Woo South Korea 7 127 0.9× 186 1.7× 77 1.1× 25 0.4× 62 1.3× 14 346
A Varaiya India 10 50 0.4× 106 1.0× 80 1.2× 37 0.7× 58 1.2× 26 296
Ya‐Fen Tang Taiwan 10 143 1.0× 195 1.8× 56 0.8× 24 0.4× 75 1.5× 14 363
Alper Tünger Türkiye 13 203 1.5× 107 1.0× 122 1.8× 73 1.3× 51 1.0× 41 437
Wantana Paveenkittiporn Thailand 12 100 0.7× 158 1.4× 69 1.0× 37 0.7× 110 2.2× 25 369
Mohamad Yasmin United States 11 135 1.0× 255 2.3× 81 1.2× 30 0.5× 63 1.3× 20 410
Mustafa Aydın Çevik Türkiye 8 125 0.9× 156 1.4× 64 0.9× 33 0.6× 49 1.0× 12 353

Countries citing papers authored by Juan Carlos Tinoco

Since Specialization
Citations

This map shows the geographic impact of Juan Carlos Tinoco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Carlos Tinoco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Carlos Tinoco more than expected).

Fields of papers citing papers by Juan Carlos Tinoco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Carlos Tinoco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Carlos Tinoco. The network helps show where Juan Carlos Tinoco may publish in the future.

Co-authorship network of co-authors of Juan Carlos Tinoco

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Carlos Tinoco. A scholar is included among the top collaborators of Juan Carlos Tinoco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Carlos Tinoco. Juan Carlos Tinoco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guzmán-Holst, Adriana, et al.. (2025). Clinical and economic burden of herpes zoster in Mexico: A retrospective medical chart analysis in a private healthcare setting. Human Vaccines & Immunotherapeutics. 21(1). 2563199–2563199.
2.
Tinoco, Juan Carlos, et al.. (2025). Interdisciplinariedad entre Matemática y Física: estrategias de resolución para problemas de proporcionalidad simple. Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona). 1–20. 2 indexed citations
3.
Deshpande, Lalitagauri M., Silvio Vega, Juan Carlos Tinoco, & Mariana Castanheira. (2023). Endemicity of Pseudomonas aeruginosa producing IMP-18 and/or VIM-2 MBLs from the high-risk clone ST111 in Central America. JAC-Antimicrobial Resistance. 5(4). dlad092–dlad092. 4 indexed citations
4.
5.
Boutry, Céline, Meng Shi, Javier Díez‐Domingo, et al.. (2020). 8. The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZOE-50 and ZOE-70). Open Forum Infectious Diseases. 7(Supplement_1). S4–S5. 6 indexed citations
6.
González, Gloria M., Rogelio de J. Treviño‐Rangel, Hiram Villanueva‐Lozano, et al.. (2020). Surveillance of antimicrobial resistance in Serratia marcescens in Mexico.. PubMed. 43(1). 34–37. 9 indexed citations
7.
Ponce‐de‐León, Alfredo, Eduardo Rodríguez-Noriega, Rayo Morfín‐Otero, et al.. (2018). Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). PLoS ONE. 13(6). e0198621–e0198621. 33 indexed citations
8.
Tinoco, Juan Carlos, Christine Juergens, Guillermo M. Ruiz Palacios, et al.. (2014). Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico. Clinical and Vaccine Immunology. 22(2). 185–192. 15 indexed citations
9.
10.
Llaca-Díaz, Jorge, Rayo Morfín‐Otero, Juan Carlos Tinoco, et al.. (2013). Virulence and Antibiotic Resistance of Enterococcus faecalis Clinical Isolates Recovered from Three States of Mexico. Detection of Linezolid Resistance. Archives of Medical Research. 44(6). 422–428. 10 indexed citations
11.
Katahira, Eva J., Amy E. Bryant, Rayo Morfín‐Otero, et al.. (2012). Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999–2010. International Journal of Infectious Diseases. 16(3). e178–e181. 35 indexed citations
12.
Alcántar-Curiel, Marı́a Dolores, et al.. (2004). Nosocomial Bacteremia and Urinary Tract Infections Caused by Extended‐Spectrum β‐Lactamase–ProducingKlebsiella pneumoniaewith Plasmids Carrying Both SHV‐5 and TLA‐1 Genes. Clinical Infectious Diseases. 38(8). 1067–1074. 48 indexed citations
13.
Martínez‐Aguilar, Gerardo, et al.. (2001). Outbreak of Nosocomial Sepsis and Pneumonia in a Newborn Intensive Care Unit by Multiresistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae High Impact on Mortality. Infection Control and Hospital Epidemiology. 22(11). 725–728. 37 indexed citations
14.
Martínez‐Aguilar, Gerardo, et al.. (2001). Outbreak of Nosocomial Sepsis and Pneumonia in a Newborn Intensive Care Unit by Multiresistant Extended-Spectrum β-Lactamase-ProducingKlebsiella pneumoniaeHigh Impact on Mortality. Infection Control and Hospital Epidemiology. 22(11). 725–728. 9 indexed citations
15.
Tinoco, Juan Carlos, Luis Huicho, Hugo Trujillo, et al.. (2000). Clinical and Bacteriologic Efficacy of Amoxycillin b.d. (45 mg/kg/day)VersusAmoxycillin t.d.s (40 mg/kg/day) in Children with Group A b-hemolytic Streptococcal Tonsillopharyngitis. Journal of Chemotherapy. 12(5). 396–405. 4 indexed citations
16.
Tinoco, Juan Carlos, et al.. (1997). Epidemiología de las infecciones nosocomiales en un hospital de segundo nivel. Salud Pública de México. 39(1). 25–31. 11 indexed citations
17.
Tinoco, Juan Carlos, et al.. (1994). [Nosocomial urinary tract infections at a second-level hospital].. PubMed. 36(1). 17–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naser Eldin Bilal Breakdown of academic impact, for papers by Jolanta Miciulevičienė Breakdown of academic impact, for papers by Dilek Arman Breakdown of academic impact, for papers by Jun-Hee Woo Breakdown of academic impact, for papers by A Varaiya Breakdown of academic impact, for papers by Ya‐Fen Tang Breakdown of academic impact, for papers by Alper Tünger Breakdown of academic impact, for papers by Wantana Paveenkittiporn Breakdown of academic impact, for papers by Mohamad Yasmin Breakdown of academic impact, for papers by Mustafa Aydın Çevik
Rankless by CCL
2026